Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
MDs in Germany join after 17 senior hires in the US over 16 months -
The Italian maker of luxury gym equipment rose over 7% in trading on Friday following the Saudi entry into the stock
-
Euro primary continues pumping out trades with JDE Peet's and Covivio lining up
-
Swiss pharma company navigates a difficult market to pay a negative to zero new issue premium
-
Strong name recognition helps Swiss pharma company achieve size at a tight price
-
Novartis spin off looks to build on jubilant reception it had last month in Swissies
